Search Results - "Lawrence, Julia A"

Chronic Statin Administration May Attenuate Early Anthracycline-Associated Declines in Left Ventricular Ejection Function by Chotenimitkhun, Runyawan, MD, D'Agostino, Ralph, PhD, Lawrence, Julia A., MD, Hamilton, Craig A., PhD, Jordan, Jennifer H., PhD, Vasu, Sujethra, MD, Lash, Timothy L., DSc, Yeboah, Joseph, MD, MPH, Herrington, David M., MD, MPH, Hundley, W. Gregory, MD

“…Abstract Background Recent studies have shown an association between statin therapy and a reduced risk of heart failure among breast cancer survivors. Our goal…”
Get full text

Preferences for breast cancer survivorship care by rural/urban residence and age at diagnosis by Weaver, Kathryn E., Nightingale, Chandylen L., Lawrence, Julia A., Talton, Jennifer, Hauser, Sally, Geiger, Ann M.

“…Purpose Preferences for survivorship care among recently treated breast cancer survivors may vary by rural-urban residence and age, but potential differences…”
Get full text

Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic resonance by Jordan, Jennifer H, D'Agostino, Jr, Ralph B, Hamilton, Craig A, Vasu, Sujethra, Hall, Michael E, Kitzman, Dalane W, Thohan, Vinay, Lawrence, Julia A, Ellis, Leslie R, Lash, Timothy L, Hundley, W Gregory

“…In a murine anthracycline-related cardiotoxicity model, increases in cardiovascular magnetic resonance myocardial contrast-enhanced T1-weighted signal…”
Get full text

Disparities in barriers to follow-up care between African American and White breast cancer survivors by Palmer, Nynikka R. A., Weaver, Kathryn E., Hauser, Sally P., Lawrence, Julia A., Talton, Jennifer, Case, L. Douglas, Geiger, Ann M.

“…Purpose Despite recommendations for breast cancer survivorship care, African American women are less likely to receive appropriate follow-up care, which is…”
Get full text

A retrospective review of the metabolic syndrome in women diagnosed with breast cancer and correlation with estrogen receptor by Colonna, Sarah V., Douglas Case, L., Lawrence, Julia A.

“…Women diagnosed with obesity and breast cancer have an increased risk of recurrence and death (Protani et al., Breast Cancer Res Treat 123:627–635, 1 )…”
Get full text

Breast cancer subtype affects patterns of failure of brain metastases after treatment with stereotactic radiosurgery by Vern-Gross, Tamara Z., Lawrence, Julia A., Case, L. Douglas, McMullen, Kevin P., Bourland, J. Daniel, Metheny-Barlow, Linda J., Ellis, Thomas L., Tatter, Stephen B., Shaw, Edward G., Urbanic, James J., Chan, Michael D.

“…We investigate the variance in patterns of failure after Gamma Knife™ radiosurgery (GKRS) for patients with brain metastases based on the subtype of the…”
Get full text

Phase I Clinical Trial of Alitretinoin and Tamoxifen in Breast Cancer Patients: Toxicity, Pharmacokinetic, and Biomarker Evaluations by LAWRENCE, Julia A, ADAMSON, Peter C, COWAN, Kenneth H, KAISER, Muriel, O'SHAUGHNESSY, Joyce, ZUJEWSKI, Joanne, CARUSO, Rafael, CHOW, Catherine, KLEINER, David, MURPHY, Robert F, VENZON, David J, SHOVLIN, Margaret, NOONE, Marianne, MERINO, Maria

“…To determine the overall and dose-limiting toxicities (DLTs) of alitretinoin (9-cis-retinoic acid) in combination with tamoxifen and the pharmacokinetics of…”
Get full text

Oral paricalcitol (19-nor-1,25-dihydroxyvitamin D2) in women receiving chemotherapy for metastatic breast cancer: A feasibility trial by Lawrence, Julia A., Akman, Steven A., Melin, Susan A., Case, L. Douglas, Schwartz, Gary G.

“…The vitamin D hormone, [1,25(OH) 2 D, calcitriol], inhibits proliferation and angiogenesis in breast cancer but its therapeutic use is limited by…”
Get full text

Cognitive Factors Associated with Adherence to Oral Antiestrogen Therapy: Results from the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Study by KLEPIN, Heidi D, GEIGER, Ann M, BANDOS, Hanna, COSTANTINO, Joseph P, RAPP, Stephen R, SINK, Kaycee M, LAWRENCE, Julia A, ATKINSON, Hal H, ESPELAND, Mark A

“…Little is known about the cognitive factors associated with adherence to antiestrogen therapy. Our objective was to investigate the association between…”
Get full text

Phase I Study and Biomarker Analysis of Lapatinib and Concurrent Radiation for Locally Advanced Breast Cancer by Kimple, Randall J., Horton, Janet K., Livasy, Chad A., Shields, Janiel M., Lawrence, Julia A., Chiu, WingKeung M., Ivanova, Anastasia, Ollila, David W., Carey, Lisa A., Halle, Jan S., Sartor, Carolyn I., Dees, E. Claire

“…Purpose. This phase I study assessed the toxicity and safety of combining daily lapatinib with radiation therapy. Sequential tumor biopsies were obtained to…”
Get full text

PRESERVATION OF LEFT VENTRICULAR EJECTION FRACTION WITH STATINS DURING RECEIPT OF ANTHRACYCLINE BASED CHEMOTHERAPY by Chotenimitkhun, Runyawan, Jr, Ralph B. D'Agostino, Lawrence, Julia A., Hamilton, Craig A., Jordan, Jennifer, Vasu, Sujethra, Lash, Timothy L., Hundley, W.

“…In a multivariable model accounting for age, gender, comorbidities (DM, HTN, HLD), and the dose of anthracycline, the LVEF decline after statins was (-2%)…”
Get full text

Overexpression of cyclin D mRNA distinguishes invasive and in situ breast carcinomas from non-malignant lesions by Weinstat-Saslow, Debra, Merino, Maria J, Manrow, Richard E, Lawrence, Julia A, Bluth, Ray F, Wittenbel, Karl D, Simpson, Jean F, Page, David L, Steeg, Patricia S

“…The elucidation of molecular alterations that occur during human breast cancer progression may contribute to the development of preventative strategies. Using…”
Get full text

Progress in Cancer Chemoprevention by KELLOFF, GARY J., CROWELL, JAMES A., STEELE, VERNON E., LUBET, RONALD A., BOONE, CHARLES W., MALONE, WINFRED A., HAWK, ERNEST T., LIEBERMAN, RONALD, LAWRENCE, JULIA A., KOPELOVICH, LEVY, ALI, IQBAL, VINER, JAYE L., SIGMAN, CAROLINE C.

“…ABSTRACT More than 40 promising agents and agent combinations are being evaluated clinically as chemopreventive drugs for major cancer targets. A few have been…”
Get full text

Current Therapeutic Options for Breast Cancer Central Nervous System Metastases by Hemphill, M. Brian, Lawrence, Julia A.

“…Opinion statement Breast cancer metastases to the central nervous system (CNS) has devastating consequences for the individual. As treatment options for…”
Get full text

Lavage and nipple aspiration of breast ductal fluids: A source of biomarkers for environmental mutagenesis by Klein, Pamela M., Lawrence, Julia A.

“…The acquisition of breast ductal fluid by nipple aspiration and ductal lavage are simple noninvasive procedures to sample breast tissue. Nipple aspiration…”
Get full text

Identification of compounds with preferential inhibitory activity against low-Nm23-expressing human breast carcinoma and melanoma cell lines by Freije, José M.P, Lawrence, Julia A, Hollingshead, Melinda G, De La Rosa, Abel, Narayanan, Ven, Grever, Michael, Sausville, Edward A, Paull, Kenneth, Steeg, Patricia S

“…We have used the COMPARE computer algorithm and Nm23 expression as a marker of tumor metastatic potential to examine the in vitro antiproliferative activity of…”
Get full text

Molecular analysis of premalignant and carcinoma in situ lesions of the human breast by STEEG, P. S, CLARE, S. E, LAWRENCE, J. A, ZHOU, Q

Get full text

A phase II clinical trial of weekly paclitaxel and carboplatin in combination with panitumumab in metastatic triple negative breast cancer by Cowherd, S, Miller, L D, Melin, S A, Akman, S, Isom, S, Cole, J, Pullikuth, A, Lawrence, J A

“…Purpose: Women with metastatic triple negative breast cancer (TNBC) can have a poor prognosis with treatment limited to cytotoxic chemotherapy. The…”
Get full text

Progress in cancer chemoprevention: development of diet-derived chemopreventive agents by Kelloff, G J, Crowell, J A, Steele, V E, Lubet, R A, Malone, W A, Boone, C W, Kopelovich, L, Hawk, E T, Lieberman, R, Lawrence, J A, Ali, I, Viner, J L, Sigman, C C

“…Because of their safety and the fact that they are not perceived as "medicine," food-derived products are highly interesting for development as chemopreventive…”
Get more information

Cognitive factors associated with adherence to oral anti-estrogen therapy: Results from the Cognition in the Study of Tamoxifen and Raloxifene (Co-STAR) Study by Klepin, Heidi D., Geiger, Ann M., Bandos, Hanna, Costantino, Joseph P., Rapp, Stephen R., Sink, Kaycee M., Lawrence, Julia A., Atkinson, Hal H., Espeland, Mark A.

“…Little is known about the cognitive factors associated with adherence to anti-estrogen therapy. Our objective was to investigate the association between…”
Get full text